AstraZeneca advances response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine Read more
Catalent Announces Acquisition of Japanese Facility to Provide Local and Global Clinical Supply Solutions Read more
Lynparza approved in the US for HRR gene-mutated metastatic castration-resistant prostate cancer Read more
FDA Approves Octapharma USA Investigational New Drug Application for Severe COVID-19 Patients Read more
Gilead and Galapagos Announce Positive Topline Results of Phase 2b/3 Trial of Filgotinib in Moderately to Severely Active Ulcerative Colitis Read more
INOVIO’s COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models Read more
Tolero Pharma Submits Investigational New Drug Application for Experimental PKM2 Activator TP-1454 Read more